Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting

Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review

(2019) Adérson Omar Mourão Cintra Damião et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Real-world biologic treatment and associated cost in patients with inflammatory bowel disease

(2019) Alina Brandes et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detections of complications

(2018) Christian Maaser et al.   Journal of Crohns & Colitis

Aktualisierte S3-Leitlinie Colitis ulcerosa der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS)

(2018) et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

PGI1 - ADVERSE EVENTS ASSOCIATED WITH THE TREATMENT OF INFLAMMATORY BOWEL DISEASE IN GERMANY

(2018) T. Wilke et al.   VALUE IN HEALTH

UEG Week 2018 Poster Presentations

(2018)   United European Gastroenterology Journal

Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease

(2017) Linda A. Feagins et al.   INFLAMMATORY BOWEL DISEASES

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

(2017) Marcus Harbord et al.   Journal of Crohns & Colitis

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

(2017) Siew C Ng et al.   LANCET

High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab – a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)

(2017) Tero Ylisaukko-oja et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Conditions of prescription of anti-TNF agents in newly treated patients with inflammatory bowel disease in France (2011–2013)

(2016) Pierre-Olivier Blotière et al.   DIGESTIVE AND LIVER DISEASE

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

(2016) Fernando Gomollón et al.   Journal of Crohns & Colitis

The global burden of IBD: from 2015 to 2025

(2015) Gilaad G. Kaplan   Nature Reviews Gastroenterology & Hepatology

Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn’s disease

(2014) Sunanda V. Kane et al.   CURRENT MEDICAL RESEARCH AND OPINION

Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with Inflammatory Bowel Disease — An ECCO-EpiCom study☆

(2014) J. Burisch et al.   Journal of Crohns & Colitis

Aktualisierte Leitlinie zur Diagnostik und Therapie der Colitis ulcerosa 2011 – Ergebnisse einer Evidenzbasierten Konsensuskonferenz

(2011) A. Dignass et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine

(2009) M. WAHED et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS